Latest Sustainable Growth News

Etherstack has landed its eighth contract deploying digital radio technology for the world's largest iron ore producer in Western Australia, reinforcing its foothold in a critical mining communications sector.

Pantoro Limited delivered a solid December quarter with gold production within guidance and positive cash flows for the fourth consecutive quarter, prompting an upward revision to its FY2025 production target. The company’s strategic focus on underground expansion and asset optimisation underpins its growth trajectory.

Vection Technologies has secured an additional $0.5 million in sales for its Algho AI platform, reinforcing its foothold in the European market and accelerating its integrated AI and XR strategy.

Vinyl Group Ltd has successfully closed its retail entitlement offer, raising $7.65 million to complete the acquisition of Concrete Playground Pty Ltd and strengthen its cash reserves. The offer garnered strong support from shareholders, underscoring confidence in the company’s strategic direction.

Wellnex Life has negotiated a delayed and reduced-cost payment arrangement for its Pain Away acquisition, aligning with its upcoming London Stock Exchange dual listing plans. The move supports the company’s growth momentum following record revenues from Pain Away.

Ava Risk Group reports a 20% revenue increase in H1 FY2025, driven by robust sales order intake and strategic expansion in key security sectors.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

Pro Medicus has secured a $33 million, nine-year contract to implement its Visage 7 cloud-based imaging platform across the University of Kentucky’s health system, marking a significant expansion in North American academic healthcare.

Genesis Minerals Limited reported a record December quarter gold production of 57,055oz, driven by an accelerated Laverton mill restart and strong operational execution. The company’s cash reserves surged 34% to A$238 million, underpinning its debt-free growth strategy.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.